Loading organizations...
Key people at Aligo Venture Capital.
Aligo Venture Capital is an early-stage venture capital firm based in the United States that invests in innovative startups operating within the Polish innovation ecosystem. The firm operates on a traditional venture capital business model, providing financial backing and strategic resources to emerging companies in exchange for equity stakes. Like standard investment vehicles, the organization generates revenue through management fees and carried interest on investment returns utilizing capital raised from limited partners. Although specific metrics regarding total assets under management, funding raised, or employee count remain undisclosed, the firm has maintained an active presence in the European startup landscape for nearly a decade. Recognizable portfolio companies, lead investors, and targeted industry sectors are not publicly detailed by the firm at this time. Aligo Venture Capital was founded in 1999 by currently undisclosed founders.
Aligo Venture Capital is an early-stage venture capital firm based in Poland, active in the local innovation ecosystem for nearly a decade. It focuses on HealthTech and CleanTech sectors, investing €0.2-1 million in innovators addressing global challenges through technologies with worldwide potential.[1][2][3][4][5][6] The firm's mission centers on supporting entrepreneurs at every stage of building valuable companies, emphasizing collaborative partnerships with founders.[3][4][5][6] Its investment philosophy prioritizes high-impact technologies in healthcare and clean energy, contributing to Poland's startup ecosystem via funding, networking events like the "Founders, Friends & Fools Dinner," and community-building in HealthTech.[1][5]
Aligo Venture Capital emerged within Poland's innovation landscape around 2016, operating for nearly a decade as of recent profiles.[2][4] Headquartered at Skarszewska 23, 83-110 Poland (with contact 695 954 203), it has evolved from a healthcare-focused investor to one emphasizing both HealthTech and CleanTech.[1][3][6] Key details on founding partners remain limited in public sources, but the firm positions itself as a hands-on player working directly with founders on global-scale ventures.[4][5] Its growth reflects Poland's rising startup scene, marked by active participation in ecosystem events to foster HealthTech advancements.[5]
Aligo rides the wave of HealthTech and CleanTech megatrends, fueled by global demands for sustainable energy and advanced healthcare amid climate change and post-pandemic innovation.[3][5][6] Its timing aligns with Poland's burgeoning startup ecosystem, where EU funding and regional talent pools amplify early-stage opportunities in these high-growth areas.[2][4] Market forces like Europe's green transition policies and rising HealthTech adoption (e.g., telemedicine, biotech) favor Aligo's portfolio, positioning it to influence local founders toward global exports.[1][3] By organizing networking events, it strengthens Poland's tech community, bridging innovators with resources and accelerating ecosystem maturity.[5]
Aligo is poised to expand its influence as HealthTech and CleanTech attract more institutional capital, potentially scaling investments or co-investing internationally. Trends like AI-driven healthcare and renewable tech will shape its pipeline, with Poland's ecosystem growth enabling larger exits. Its founder-centric model could evolve into broader operating support, amplifying impact in Europe's innovation map—echoing its core role in nurturing global challengers from a Polish base.[3][4][5][6]
Key people at Aligo Venture Capital.
